Literature DB >> 16491120

The tumor suppressor p16Ink4a regulates T lymphocyte survival.

T Bianchi1, N Rufer, H R MacDonald, M Migliaccio.   

Abstract

In contrast to other cell cycle inhibitors, the tumor suppressor p16Ink4a is not detectable or expressed at very low levels in embryonic and adult mouse tissues, and therefore it has often been considered as a specialized checkpoint protein that does not participate in the control of normal cell cycle progression. However, Ink4a-/- mice possess increased thymus size and cellularity, thus suggesting the involvement of p16(Ink4a) in the control of thymocyte proliferation. In this study, we found increased numbers of CD8 and CD4 T lymphocytes in thymus and spleen from Ink4a-/- mice. Unexpectedly, this was not related to an increase in T-cell division rates, which were similar in lymphoid organs of Ink4a-/- and wild-type mice. In contrast, T-cell apoptosis rates were significantly decreased in thymus and spleen from Ink4a-/- mice. Moreover, whereas p16Ink4a-deficient and wild-type T cells were equally sensitive to Fas or TCR-mediated apoptosis, the former were clearly more resistant to apoptosis induced by oxidative stress or gamma irradiation. Our results indicate that p16Ink4a function is associated with T-cell apoptosis, and subsequently contributes to the control of T-cell population size in lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491120     DOI: 10.1038/sj.onc.1209437

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.

Authors:  Johan Jansson; Yu-Chiao Hsu; Igor I Kuzin; Andrew Campbell; Craig A Mullen
Journal:  Leuk Res       Date:  2010-11-12       Impact factor: 3.156

Review 2.  Genetic regulation of thymocyte progenitor aging.

Authors:  Beata Berent-Maoz; Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Semin Immunol       Date:  2012-05-02       Impact factor: 11.130

3.  Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a.

Authors:  Beata Berent-Maoz; Encarnacion Montecino-Rodriguez; Robert A J Signer; Kenneth Dorshkind
Journal:  Blood       Date:  2012-05-03       Impact factor: 22.113

4.  Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.

Authors:  Yan Liu; Soren M Johnson; Yuri Fedoriw; Arlin B Rogers; Hong Yuan; Janakiraman Krishnamurthy; Norman E Sharpless
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

Review 5.  The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis.

Authors:  Kay-Dietrich Wagner; Nicole Wagner
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

Review 6.  Tumor suppressor mechanisms in immune aging.

Authors:  Yan Liu; Norman E Sharpless
Journal:  Curr Opin Immunol       Date:  2009-06-15       Impact factor: 7.486

7.  High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.

Authors:  Faith M Young; Andrew Campbell; Kris Lambert Emo; Johan Jansson; Pin-Yi Wang; Craig T Jordan; Craig A Mullen
Journal:  Biol Blood Marrow Transplant       Date:  2008-04-14       Impact factor: 5.742

8.  Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.

Authors:  Lenka Skalska; Robert E White; Gillian A Parker; Ernest Turro; Alison J Sinclair; Kostas Paschos; Martin J Allday
Journal:  PLoS Pathog       Date:  2013-02-21       Impact factor: 6.823

9.  Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis development.

Authors:  Kristiaan Wouters; Céline Cudejko; Marion J J Gijbels; Lucia Fuentes; Kadiombo Bantubungi; Jonathan Vanhoutte; Rebecca Dièvart; Charlotte Paquet; Emmanuel Bouchaert; Sarah Anissa Hannou; Florence Gizard; Anne Tailleux; Menno P J de Winther; Bart Staels; Réjane Paumelle
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

10.  Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers.

Authors:  Albert Stuart Reece
Journal:  Immun Ageing       Date:  2007-09-24       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.